secwatch.observer — SEC 8-K summary
======================================

Issuer:     MetaVia Inc. (MTVA)
CIK:        0001638287
Form:       8-K
Filed at:   2024-11-18T23:59:59+00:00
Accession:  0001558370-24-015839
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroBo to rename to MetaVia Nov 29; ticker changes to MTVA
-----------------------------------------------------------

- NeuroBo Pharmaceuticals changes legal name to MetaVia Inc., effective Nov 29, 2024.
- Nasdaq ticker symbol changes from NRBO to MTVA on the same date.
- No shareholder vote required; CUSIP and transfer agent unchanged.
- Company expects Phase 2a data for DA-1241 (MASH) in Dec 2024 and Phase 1 obesity data in Q1 2025.
- June financing of up to $70M ($20M upfront, $50M warrants) provides funding runway.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638287/000155837024015839/0001558370-24-015839-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638287/000155837024015839/nrbo-20241115x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-015839

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer